Jay Portnoy
Pediatric Allergy/Immunology · Kansas City, MONPI 1568429066
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 28.8% of the total. Reporting peaked in 2019 at $20,982 and has fallen 96.9% since, to $655 in 2025. Among pediatric allergy/immunology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $592.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$22K
- Phadia US Inc.$14K
- Novartis$8K
- Genentech USA, Inc.$6K
- Boehringer Ingelheim$6K
- CSL Behring$5K
- plus $14K from 15 others
Across 48 payments — averaging $605.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aimmune Therapeutics, Inc.$22K
- Merck$4K
- Teva Pharmaceuticals USA, Inc.$3K
What the payments were for
- Consulting fees$39,85353%
- Speaking & faculty fees$27,20936%
- Travel & lodging$2,7364%
- Food & beverage$6,0418%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $21,859 |
| Phadia US Inc. | 12 | $14,412 |
| Novartis | 9 | $7,548 |
| Genentech USA, Inc. | 11 | $6,463 |
| Boehringer Ingelheim | 9 | $6,040 |
| CSL Behring | 7 | $5,132 |
| Alk-abello, Inc | 7 | $4,159 |
| Aimmune Therapeutics, Inc. | 2 | $2,892 |
| Biocryst US Sales Co., LLC | 10 | $1,626 |
| AstraZeneca | 17 | $1,519 |
| Biocryst Pharmaceuticals, Inc. | 1 | $1,375 |
| Regeneron Healthcare Solutions, Inc. | 9 | $918 |
| GSK | 9 | $777 |
| Sanofi | 6 | $376 |
| Ionis Pharmaceuticals, Inc. | 1 | $124 |
| Pfizer | 1 | $123 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $120 |
| Amgen | 1 | $94 |
| Grifols USA, LLC | 1 | $86 |
| Genentech, Inc. | 2 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProAir Digihaler$16,525
- ImmunoCAP$14,332
- XOLAIR$13,529
- Odactra$3,861
- Ragwitek$3,861
- Grastek$3,861
- ArmonAir Digihaler$3,525
- PALFORZIA$2,875
- AirDuo Digihaler$1,845
- AirDuo RespiClick$1,680
- Orladeyo$1,375
- DUPIXENT$1,177
- FASENRA$622
- GILENYA$514
- NUCALA$462
- TEZSPIRE$354
- DAWNZERA$124
- EUCRISA$123
- HYQVIA$120
- NEFFY$102
How this compares
$75,839 in reported general payments places this provider in the 95th percentile of 22 pediatric allergy/immunology providers in Missouri.
See all pediatric allergy/immunology providers in Missouri →
Other pediatric allergy/immunology in Kansas City
- Mary JacobsonKansas City$4K
- Thao leKansas City$1K
- Kevin HyerKansas City$116
- Paul DowlingKansas City$88
- Gary GoodmanSaint Louis$54K
- Deepika PolineniSaint Louis$39K
- Ray DavisSaint Louis$14K
- William JohnsonSaint Louis$7K
- Lisa SuffianSaint Louis$5K
- Alan KnutsenSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.